HCW11-018

N/A

Report date: 2026/04/13 20:02:18

Base Information

Drug NameHCW11-018
Drug Alias NameHCW11-018HCW11-018b
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > T cell engagers
Mechanisms of ActionT lymphocytes stimulantsImmunologic cytotoxicity
TargetsTissue factorT cell surface glycoprotein CD3Interleukin-15
Therapy Area/IndicationsOvarian NeoplasmsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHCW Biologics Inc
China Registration ClassN/A

Develop Information

Active CompaniesHCW Biologics Inc
Inactive CompaniesN/A
Active IndicationsOvarian NeoplasmsPancreatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A